434 The study design of two trials of dupilumab in patients with prurigo nodularis inadequately controlled with topical therapies: LIBERTY PN PRIME and PRIME 2

Journal article

Peer reviewed

G. Yosipovitch, N. Mollanazar, S. Ständer, S.G. Kwatra, J. Luo, N. Amin, L.P. Mannent, E. Laws, A. Bansal and J.T. O'Malley

Journal of investigative dermatology, Vol.141(5), p.S75

2021-05

Metrics

15 Record Views

Title: 434 The study design of two trials of dupilumab in patients with prurigo nodularis inadequately controlled with topical therapies: LIBERTY PN PRIME and PRIME 2
Creators: G. Yosipovitch - University of Miami
N. Mollanazar - University of Pennsylvania
S. Ständer - University Hospital Münster
S.G. Kwatra - Johns Hopkins University
J. Luo - Sanofi
N. Amin - Regeneron
L.P. Mannent - Sanofi
E. Laws - Sanofi
A. Bansal - Regeneron
J.T. O'Malley - Sanofi, Cambridge, Massachusetts, United States
Publication Details: Journal of investigative dermatology, Vol.141(5), p.S75
Academic Unit: Miller School of Medicine; UMMG Dept of Dermatology & Cutaneous Surgery
Language: English
Resource Type: Journal article
Record Identifier: 991031713484402976